HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan Lu Selected Research

Carcinogenesis

10/2023Transcriptional background effects on a tumor driver gene in different pigment cell types of medaka.
1/2022Particulate hexavalent chromium alters microRNAs in human lung cells that target key carcinogenic pathways.
1/2020SNHG5 functions as competitive RNA with miR-23c to regulate HMGB2 expression in hepatocellular carcinoma.
1/2020Nanos3, a cancer-germline gene, promotes cell proliferation, migration, chemoresistance, and invasion of human glioblastoma.
1/2019miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.
11/2015Genes targeted by the Hedgehog-signaling pathway can be regulated by Estrogen related receptor β.
12/2014Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model.
10/2013U87MG glioma cells overexpressing IL-17 acclerate early-stage growth in vivo and cause a higher level of CD31 mRNA expression in tumor tissues.
9/2011The profile of Th17 subset in glioma.
9/2009Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan Lu Research Topics

Disease

65Neoplasms (Cancer)
03/2024 - 02/2002
27Inflammation (Inflammations)
11/2023 - 10/2012
24Hypertension (High Blood Pressure)
02/2024 - 02/2008
19Hepatocellular Carcinoma (Hepatoma)
01/2024 - 12/2003
15Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 01/2005
13Heart Failure
02/2024 - 04/2010
10ST Elevation Myocardial Infarction
04/2024 - 01/2021
10Myocardial Infarction
02/2024 - 01/2017
10Fibrosis (Cirrhosis)
02/2024 - 08/2008
10Carcinogenesis
10/2023 - 09/2009
9Endometriosis
11/2023 - 11/2008
9Glioma (Gliomas)
01/2020 - 02/2002
8Asthma (Bronchial Asthma)
01/2024 - 11/2016
7Lung Neoplasms (Lung Cancer)
04/2024 - 01/2016
7Stroke (Strokes)
02/2024 - 04/2011
7Reperfusion Injury
12/2023 - 06/2006
7Crohn Disease (Crohn's Disease)
01/2023 - 01/2013
7Carcinoma (Carcinomatosis)
10/2022 - 03/2009
7Liver Neoplasms (Liver Cancer)
09/2022 - 12/2010
7COVID-19
01/2022 - 05/2020
7Ischemia
12/2021 - 01/2005
7Infections
01/2021 - 02/2005
7Sleepiness
01/2019 - 09/2015
7Leukemia
10/2017 - 12/2005
6Myocardial Ischemia (Ischemic Heart Diseases)
02/2024 - 12/2018
6Acute Kidney Injury (Acute Renal Failure)
02/2024 - 04/2014
6Melanoma (Melanoma, Malignant)
11/2023 - 01/2017
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2016
6Hypoxia (Hypoxemia)
11/2023 - 06/2003
6Ovarian Neoplasms (Ovarian Cancer)
03/2020 - 01/2003
6Narcolepsy
01/2019 - 09/2015
5Breast Neoplasms (Breast Cancer)
10/2023 - 11/2004
5Wounds and Injuries (Trauma)
10/2023 - 03/2010
5Ulcerative Colitis
07/2022 - 12/2012
5Neoplasm Metastasis (Metastasis)
01/2022 - 03/2007
5Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2020 - 03/2013
5Hypersensitivity (Allergy)
01/2020 - 03/2013
5Prostatic Neoplasms (Prostate Cancer)
12/2015 - 03/2007
4Type 2 Diabetes Mellitus (MODY)
02/2024 - 04/2011
4Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 01/2019
4Necrosis
03/2023 - 04/2010
4Thrombosis (Thrombus)
03/2022 - 04/2011
4Nausea
01/2019 - 09/2015
4Headache (Headaches)
01/2019 - 09/2015
4Alzheimer Disease (Alzheimer's Disease)
01/2016 - 03/2012
4Atherosclerosis
10/2013 - 11/2004
3Pain (Aches)
02/2024 - 04/2010
3Lung Injury
01/2024 - 10/2017
3Atrial Fibrillation
12/2023 - 07/2022
3Communicable Diseases (Infectious Diseases)
11/2023 - 12/2012
3Colitis
01/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
11/2023 - 09/2004
20Biomarkers (Surrogate Marker)IBA
10/2022 - 11/2008
17Messenger RNA (mRNA)IBA
01/2024 - 02/2002
12MicroRNAs (MicroRNA)IBA
02/2024 - 07/2009
11RNA (Ribonucleic Acid)IBA
01/2024 - 02/2002
9Antihypertensive Agents (Antihypertensives)IBA
01/2023 - 12/2017
9solriamfetolIBA
01/2019 - 09/2015
8CholesterolIBA
01/2021 - 11/2004
8LipidsIBA
01/2021 - 11/2004
7C-Reactive ProteinIBA
04/2024 - 03/2015
7Therapeutic UsesIBA
02/2024 - 12/2014
7EnzymesIBA
10/2023 - 01/2013
7Doxorubicin (Adriamycin)FDA LinkGeneric
03/2023 - 05/2015
7DNA (Deoxyribonucleic Acid)IBA
08/2011 - 01/2007
6Phosphotransferases (Kinase)IBA
01/2024 - 07/2010
6CytokinesIBA
11/2023 - 09/2011
6Glucose (Dextrose)FDA LinkGeneric
01/2023 - 08/2013
6Monoclonal AntibodiesIBA
11/2018 - 06/2002
5Blood Glucose (Blood Sugar)IBA
02/2024 - 04/2011
5Apolipoproteins E (ApoE)IBA
07/2022 - 12/2012
5Long Noncoding RNAIBA
01/2021 - 11/2019
5Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
10/2013 - 08/2008
4Hematoxylin (Haematoxylon)IBA
02/2024 - 01/2017
4Dopamine (Intropin)FDA LinkGeneric
01/2022 - 01/2019
4ErbB Receptors (EGF Receptor)IBA
08/2021 - 01/2016
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018 - 09/2007
4salicylhydroxamic acid (SHAM)IBA
07/2018 - 11/2004
4bapineuzumabIBA
01/2016 - 03/2012
4Small Interfering RNA (siRNA)IBA
01/2016 - 12/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2013 - 06/2003
3omega-Chloroacetophenone (Mace)IBA
02/2024 - 01/2021
3Sodium-Glucose Transporter 2 InhibitorsIBA
02/2024 - 04/2011
3Eosine Yellowish-(YS) (Eosin)IBA
02/2024 - 01/2017
3scutellarinIBA
12/2023 - 09/2016
3shenxiong glucoseIBA
12/2023 - 11/2017
3InterferonsIBA
11/2023 - 05/2003
3Hormones (Hormone)IBA
10/2023 - 03/2009
3Caspase 3 (Caspase-3)IBA
03/2023 - 09/2009

Therapy/Procedure

43Therapeutics
03/2024 - 02/2003
14Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2024 - 01/2014
13Moxibustion
01/2023 - 12/2012
12Percutaneous Coronary Intervention
02/2024 - 12/2018
9Drug Therapy (Chemotherapy)
10/2023 - 05/2005
4Electroacupuncture
07/2022 - 03/2013
3Ambulatory Care (Outpatient Care)
02/2024 - 01/2021
3Patient Readmission
01/2024 - 06/2023
3Cardiac Rehabilitation
12/2023 - 01/2023
3Immunotherapy
11/2023 - 11/2015
3Radiotherapy
10/2023 - 01/2013